Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to a DMARD Starting a New bDMARD or tsDMARD Treatment +/- csDMARD

NCT05936970 is registered in ClinicalTrials.gov with Aqtual, Inc. as lead sponsor.

NCT NCT05936970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05936970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to a DMARD Starting a New bDMARD or tsDMARD Treatment +/- csDMARD
Lead sponsor
Aqtual, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
June 29, 2023
Completion date
June 30, 2028
Enrollment
1,410 (estimated)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis